362 related articles for article (PubMed ID: 18243754)
1. [Seroma after axillary lymph node dissection in breast cancer].
Douay N; Akerman G; Clément D; Malartic C; Morel O; Barranger E
Gynecol Obstet Fertil; 2008 Feb; 36(2):130-135. PubMed ID: 18243754
[TBL] [Abstract][Full Text] [Related]
2. [Axillary lymphocele after axillary dissection or sampling of sentinel lymph node in breast cancer].
Bijek JH; Aucouturier JS; Doridot V; Ghemari T; Nos C
Bull Cancer; 2005 Feb; 92(2):179-83. PubMed ID: 15749647
[TBL] [Abstract][Full Text] [Related]
3. Use of Low-Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma.
Conversano A; Mazouni C; Thomin A; Gaudin A; Fournier M; Rimareix F; Bonastre J
Clin Breast Cancer; 2017 Jul; 17(4):293-297. PubMed ID: 28161131
[TBL] [Abstract][Full Text] [Related]
4. OK-432 (Sapylin) Reduces Seroma Formation After Axillary Lymphadenectomy in Breast Cancer.
Kong D; Liu Y; Li Z; Cui Q; Wang K; Wu K; Wu G
J Invest Surg; 2017 Feb; 30(1):1-5. PubMed ID: 27431576
[TBL] [Abstract][Full Text] [Related]
5. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic Axillary Seroma after Sentinel Lymph Node Biopsy: Incidence and Treatment.
Gunn J; Gibson T; Li Z; Diehl N; Bagaria S; McLaughlin S
Ann Surg Oncol; 2016 Oct; 23(10):3347-53. PubMed ID: 27393569
[TBL] [Abstract][Full Text] [Related]
7. The effects of low-thrombin fibrin sealant on wound serous drainage, seroma formation and length of postoperative stay in patients undergoing axillary node dissection for breast cancer. A randomized controlled trial.
Benevento R; Santoriello A; Pellino G; Sciaudone G; Candilio G; De Fatico GS; Selvaggi F; ; Canonico S
Int J Surg; 2014 Nov; 12(11):1210-5. PubMed ID: 25462702
[TBL] [Abstract][Full Text] [Related]
8. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
9. Overnight closed suction drainage after axillary lymphadenectomy for breast cancer.
Liu CD; McFadden DW
Am Surg; 1997 Oct; 63(10):868-70. PubMed ID: 9322660
[TBL] [Abstract][Full Text] [Related]
10. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise.
Borg G; Dihge L; Johansson K
Acta Oncol; 2023 May; 62(5):444-450. PubMed ID: 37129993
[TBL] [Abstract][Full Text] [Related]
12. Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation.
Gambardella C; Clarizia G; Patrone R; Offi C; Mauriello C; Romano R; Filardo M; Conzo A; Sanguinetti A; Polistena A; Avenia N; Conzo G
BMC Surg; 2019 Apr; 18(Suppl 1):125. PubMed ID: 31074399
[TBL] [Abstract][Full Text] [Related]
13. Reduced use of drains following axillary lymphadenectomy for breast cancer.
Talbot ML; Magarey CJ
ANZ J Surg; 2002 Jul; 72(7):488-90. PubMed ID: 12123509
[TBL] [Abstract][Full Text] [Related]
14. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
Krynyckyi BR; Shim J; Lim I
Cancer; 2004 Feb; 100(3):654-5; author reply 655-6. PubMed ID: 14745886
[No Abstract] [Full Text] [Related]
15. Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma.
Bafford A; Gadd M; Gu X; Lipsitz S; Golshan M
Am J Surg; 2010 Sep; 200(3):374-7. PubMed ID: 20409517
[TBL] [Abstract][Full Text] [Related]
16. Prevention of seroma formation after axillary dissection--a comparative randomized clinical trial of three methods.
Kottayasamy Seenivasagam R; Gupta V; Singh G
Breast J; 2013; 19(5):478-84. PubMed ID: 23865902
[TBL] [Abstract][Full Text] [Related]
17. Lymph node dissection in patients with malignant melanoma is associated with high risk of morbidity.
Ul-Mulk J; Hölmich LR
Dan Med J; 2012 Jun; 59(6):A4441. PubMed ID: 22677239
[TBL] [Abstract][Full Text] [Related]
18. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
[TBL] [Abstract][Full Text] [Related]
19. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
Seyednejad N; Kuusk U; Wiseman SM
Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
[TBL] [Abstract][Full Text] [Related]
20. Seroma formation in two cohorts after axillary lymph node dissection in breast cancer surgery: does timing of drain removal matter?
Andeweg CS; Schriek MJ; Heisterkamp J; Roukema JA
Breast J; 2011; 17(4):359-64. PubMed ID: 21679270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]